Biogen Raises FY2026 GAAP EPS Guidance from $12.00-$13.00 to $12.20-$13.00 vs $5.84 Est
Benzinga News-desk 5 days ago
NewsGuidance
Biogen (NASDAQ:BIIB) lowers FY2026 Adj EPS guidance from $15.25-$16.25 to $12.20-$13.00 vs $12.36 analyst estimate..
Biogen (NASDAQ:BIIB) raised FY2026 GAAP EPS guidance from $12.00-$13.00 to $12.20-$13.00 vs $5.84 analyst estimate.